Featured products

You can also try the following methods, and our professionals will serve you Customized Consultation

Cat. No.	Product Name	Field of Application
DC11104	Tildacerfont Featured	corticotropin releasing factor (CRF) antagonist.
DC22488	Corticotropin-releasing factor (human) Featured	Corticotropin-releasing hormone (CRH) is a peptide hormone involved in the stress response..
DC23908	Cortisone Featured	Cortisone is a pregnane (21-carbon) steroid hormone, one of the main hormones released by the adrenal gland in response to stress.
DC10686	Cosan-528 Featured	Cosan-528 is a bioactive chemical.
DC10657	COTI-2 Featured	COTI-2 is a small molecule candidate anti-cancer drug which can convert mutant p53 to wild-type conformation.
DC10363	Coumestrol Featured	Coumestrol, a phytoestrogen present in soybean products, exhibits activities against cancers, neurological disorders, and autoimmune diseases. It suppresses proliferation of ES2 cells with an IC50 of 50 μM.
DC10528	CP 376395 Featured	CP 376395 is a potent and selective CRF1 receptor antagonist (Ki values are 12 and >10000 nM for CRF1 and CRF2 receptors respectively).
DC7389	CP-673451 Featured	CP 673451 is a selective inhibitor of PDGFRα/β with IC50 of 10 nM/1 nM, exhibits >450-fold selectivity over other angiogenic receptors, has antiangiogenic and antitumor activity.
DC12046	CP 105696 Featured	CP-105696 is a potent and selective Leukotriene B4 Receptor antagonist, with an IC50 of 8.42 nM.
DC9726	CP21 (CP21R7) Featured	CP21R7 is a potent and selective GSK-3β inhibitor.
DC23320	CP 31398 dihydrochloride Featured	CP-31398 is a small molecule p53 reactivator that protects p53 from thermal denaturation, not only reactivates mutant p53 but also induces stabilization of wild type p53.
DC23610	CP-339818 hydrochloride Featured	CP-339818 is a potent, selective, non-peptide KV1.3 channel antagonist with IC50 of 200 nM.
DC4112	CP466722 Featured	CP-466722 is an potent and reversible ATM inhibitor.
DC9303	Taprenepag(CP-544326) Featured	CP-544326 is a selective prostaglandin EP(2) agonist on intraocular pressure in preclinical models of glaucoma.
DC4132	CP-547632 Featured	CP-547632 is as a potent inhibitor of the VEGFR-2 and basic fibroblast growth factor (FGF) kinases (IC50 11 and 9 nM, respectively).
DC9265	CP-640186 hydrochloride Featured	CP-640186 Hcl is an isozyme-nonselective acetyl-CoA carboxylase (ACC) inhibitor with IC50s of 53 nM and 61 nM for rat liver ACC1 and rat skeletal muscle ACC2 respectively; with improved metabolic stability vs CP-610431.
DC7975	CP 640186 Featured	CP-640186 is an isozyme-nonselective acetyl-CoA carboxylase inhibitor with IC50s of 53 nM and 61 nM for rat liver ACC1 and rat skeletal muscle ACC2 respectively.
DC11410	CP-671305 Featured	CP-671305 is a potent and selective inhibitor of phosphodiesterase 4.
DC10506	CPHPC(Miridesap) Featured	CPHPC(GSK2315698,Miridesap) is a divalent crosslinker of SAP that causes rapid depletion of circulating SAP via hepatic clearance.
DC7564	CPI 0610(Pelabresib) Featured	CPI 0610 is a potent, selective, and cell-active BET bromodomain inhibitor with IC50 of 39 nM for BRD4-BD1 in TR-FRET assay.
DC9736	CPI1189(REN-1189) Featured	CPI-1189 prevents apoptosis and reduces glial fibrillary acidic protein immunostaining in a TNF-alpha infusion model for AIDS dementia complex.
DC8001	CPI 169 R-enantiomer Featured	CPI-169 R is a novel and potent EZH2 inhibitor with IC50 <1 nM(inhibition of the catalytic activity of PRC2.
DC8466	CPI-169 (racemate） Featured	CPI-169 racemate is the racemate form of CPI-169, which is a novel and potent EZH2 inhibitor with IC50 <1 nM(inhibition of the catalytic activity of PRC2); decreases cellular levels of H3K27me3 with an EC50 of 70 nM, and triggers cell cycle arrest and apo
DC5046	CPI203 (CPI-203) Featured	CPI203 is a novel potent, selective and cell permeable inhibitor of the bromodomain and extra terminal (BET) family protein BRD4 with an IC50 of ~37 nM (BRD4 α-screen assay).
DC8619	CPI-268456 Featured	CPI-268456 is a potential BET bromodomain inhibitor.
DC8002	CPI-360 (R) Featured	CPI-360 is a compound in design and preparation of wew palladium precatalysts for C-C and C-N cross-coupling reactions.
DC10527	Ciforadenant (CPI-444) Featured	CPI-444 is an orally administered antagonist of the adenosine A2A receptor. It is designed to block the action of adenosine that is produced by tumors.
DC10593	CPI-455 analogue(KDM5 inhibitor) Featured	CPI-455 analogue is a selective inhibitor of KDM5 demethylases.
DC9858	CPI-455 Featured	CPI-455 is a specific, pan-KDM5 inhibitor with an IC50 of 10 nM for KDM5A. CPI-455 mediates KDM5 inhibition, elevates global levels of H3K4me3, and decreases the number of drug-tolerant persister cancer cells in multiple cancer cell line models treated with standard chemotherapy or targeted agents.
DC10591	CPI-613 Featured	CPI-613 is an E1α pyruvate dehydrogenase (PDH) modulator that prevents cancer cells from metabolizing glucose for energy. CPI-613 has been granted orphan drug status by the US FDA for pancreatic cancer.

Featured products

Customized Consultation X

Your information is safe with us. * Required Fields.